Related Experiment Video
Updated: Jun 29, 2025
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
1.5K
Brain functional and structural changes in diabetic children. How can intellectual development be optimized in type 1
Maia Stanisławska-Kubiak1, Katarzyna Anna Majewska2, Agata Krasińska2
1Department of Clinical Psychology, Poznan University of Medical Sciences, ul. Bukowska 70, Poznan 60-812, Poland.
Therapeutic Advances in Chronic Disease
|April 1, 2024
Summary
Type 1 diabetes (T1D) can negatively impact children's brain development and cognitive functions. Maintaining stable blood sugar levels and providing tailored support are crucial for optimizing intellectual development in children with T1D.
Area of Science:
- Neuroscience
- Endocrinology
- Pediatrics
Background:
- Type 1 diabetes (T1D) management requires significant patient commitment and cognitive capacity.
- Intellectual limitations can hinder optimal metabolic control in T1D, potentially worsening cognitive function.
- Understanding the impact of T1D on brain development is critical for effective therapeutic strategies.
Purpose of the Study:
- To review current knowledge on how diabetes affects brain structure and function in children.
- To identify strategies for optimizing intellectual development in pediatric T1D patients.
Main Methods:
- A narrative synthesis of literature from Scopus, PubMed, and Web of Science.
- Keywords focused on diabetes, brain development, and cognitive function in childhood.
Main Results:
- Childhood glucose metabolism disturbances can cause lasting negative effects on brain development and cognition.
- Peri-normal glycemic levels are essential to prevent central nervous system disorders.
- Early detection of cognitive dysfunction and individualized management are vital.
Conclusions:
- Maintaining optimal glycemic control is paramount for protecting cognitive development in children with T1D.
- Repeated neuropsychological evaluations and tailored interventions are necessary.
- Multidirectional environmental support enhances intellectual development in T1D.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:15Diabetes: Symptoms, Diagnosis, and Complications
530
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
530
01:15Diabetes: Management and Pharmacotherapy
277
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277
01:20Pathophysiology of Diabetes
926
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
926
01:30Attention-Deficit/Hyperactivity Disorder
59
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
59